Atrys reports H1 2026 revenue up 9.4% and EBITDA up 21.3%
Atrys Health reported H1 2026 revenue of €77.7M, up 9.4%, with EBITDA up 21.3%. The company said net debt fell 79.2% after the ASPY sale and that full-year guidance was reaffirmed.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.